Tuberculosis and Respiratory Diseases

Search

Page Path

The Prognostic Value of the Tumor Shrinkage Rate for Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Receiving Gefitinib: Dong Il Park, Sun Young Kim, Ju Ock Kim, Sung Soo Jung, Hee Sun Park, Jae Young Moon, Chae Uk Chung, Song Soo Kim, Jae Hee Seo, Jeong Eun Lee; Tuberc Respir Dis. 2015;78(4):315-320. Published online October 1, 2015; DOI: https://doi.org/10.4046/trd.2015.78.4.315
Web of Science 4 Crossref 3; Full text PubReader PDF

Systemic Nocardiosis Mimicking Disease Flare-up after Discontinuation of Gefitinib in a Patient with EGFR-Mutant Lung Cancer: Mihong Choi, Youngjoo Lee, Sang Hyun Hwang, Jin Soo Lee; Tuberc Respir Dis. 2014;77(6):271-273. Published online December 31, 2014; DOI: https://doi.org/10.4046/trd.2014.77.6.271
Web of Science 1; Full text PubReader PDF

Tuberculosis and
Respiratory Diseases

Print ISSN: 1738-3536
Online ISSN: 2005-6184

MOST VIEWED MOST CITED

9,567	The Importance of Early Chronic Obstructive Pulmonary Disease: A Lecture from 2022 Asian Pacific Society of Respirology
4,389	Subphenotypes of Acute Respiratory Distress Syndrome: Advancing Towards Precision Medicine
2,574	Early Mobilization and Rehabilitation of Critically-Ill Patients
14,800	Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
2,341	Association between Antacid Exposure and Risk of Interstitial Lung Diseases

Cited By 26	Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
Cited By 14	Tuberculosis: Republic of Korea, 2021
Cited By 12	Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
Cited By 10	Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
Cited By 10	Pulmonary Functions and Inflammatory Biomarkers in Post-Pulmonary Tuberculosis Sequelae

Editorial Office: 101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347 Fax: +82-2-572-6683 E-mail: katrdsubmit@lungkorea.org